Skip to main content
. 2023 Jul 6;12(16):17239–17252. doi: 10.1002/cam4.6296

FIGURE 1.

FIGURE 1

Comparison of QoL (A), depression (B), and anxiety (C) between respondents with TKI dose reduction and TKI discontinuation. QoL, quality‐of‐life; TKI, tyrosine kinase inhibitor.